Browsing by Author "Shittu, RO"

Now showing 1 - 2 of 2
  • Item
    DEPRESSION AMONG PEOPLE LIVING WITH HIV/AIDS IN ILORIN, NIGERIA
    (NIGERIAN JOURNAL OF FAMILY PRACTICE, 2019) Odeigah, LO; Rotifa, SU; Shittu, RO; Olanrewaju, GJ
    Background: Depressive disorders are a significant public health problem. They are prevalent, disabling, and often chronic, with a high economic burden to the society. Although depression is common, determining its prevalence across studies and within different segments of the HIV population is not easy, given the variety of methodological issues that warrant consideration. This study estimates the prevalence of depressive disorders and its correlates. Objectives: The study sought to determine the prevalence of depression among adult HIV/AIDS respondents, attending HIV/AIDS clinic in the Kwara State specialist Hospital, Sobi, Ilorin, Nigeria. Methods: This was a hospital based, cross sectional, descriptive study of three hundred adult HIV/AIDS patients attending the HIV clinic of the Kwara State Specialist Hospital, Sobi, Ilorin from 1st of March to 3oth July, 2014. Informed consent was obtained from the respondents. The PHQ-9 was administered to the respondents to screen for depression. A pre-tested PHQ-9 questionnaire was used to collect data. Subjects who scored one and more were assessed clinically for depression. The severity of the depression was further classified as minimal, mild, moderate and severe. The three keys to social determinants of depression (SDS) were assessed and the association with depression sought. Results: One hundred and seventy (56.7%) satisfied the criteria for a depressive disorder using the PHQ-9 score. Depressive symptoms were strongly related to gender, below average year of schooling, poor economic status, low social cohesion and stressful life events. Conclusion: Clinicians should assess HIV-infected people for depression, to ensure early detection and treatment. Failure to recognize depression may endanger both the subjects and others in the community. This result calls for improved public health education and awareness to highlight the health impact of depressive symptoms among People Living with HIV/AIDS (PLWHA).
  • Item
    RIFAMPICIN RESISTANT TUBERCULOSIS IN A SECONDARY HEALTH FACILITY IN ILORIN, NIGERIA
    (NIGERIAN JOURNAL OF FAMILY PRACTICE, 2019) Odeigah, LO; Shittu, RO; Rotifa, US; Akanbi, AA; Adeoti, W
    Background: Rifampicin resistant tuberculosis is an unrecognized and potentially serious treatment issue. Rifampicin resistance is a risk factor for poor outcome in tuberculosis. It is prevalent in Nigeria. Therefore, we sought to examine the pattern of Rifampicin resistance tuberculosis in Ilorin, Nigeria. Method: One hundred and forty tuberculosis cases were referred to the chest clinic of Sobi Specialist Hospital, Ilorin from January to December, 2014. Sputum samples were obtained from them, smeared on glass slides, stained using Ziehl Neelsen Stain and later observed under light microscopy. The GeneXpert MTB/RIF assay was used to simultaneously detect TB and rifampicin resistance. Result: The minimum age of the patients was 18years, while the maximum was 83years. The mean age was 38.39± 13.75. There was male preponderance 84(60%), compared to 56(40%) female. The Sobi Specialist Hospital made the highest referral. The tertiary hospital, the University of Ilorin Teaching Hospital had no functional GeneXpert facility as at the time of this study. Forty eight (34.3%) had smear-positive TB, while 92(65.7%) were sputum negative. Thirty two (38.1%) male out of 84 and 12(21.4%) female out of 56 were sensitive to Rifampicin, while 6(7.1%) male out of 84 and 4 (7.1%) female out of 56 were resistant to it. Forty four (31.4%) were MD-TB positive with a prevalence of 31.4%. Ten (7.2%) were Rifampicin resistant; this included 6 males and females. This was statistically significant. Conclusion: Our study highlights that physicians should have a high index of suspicion for rifampicin resistant tuberculosis in patients refractory to anti-TB treatment. The MTB/RIF test is a useful method for rapid diagnosis of TB and detection of RIFresistance strains. There is need for increasing effort to interrupt the transmission of RIF-TB.